Watch world-leading scientists online, October 5, to discover the latest tools and techniques advancing Alzheimer's research, single cell characterization, biomarker discovery and more
Discover how collaborative research between big pharma and academia is using the latest proteomics platforms to revolutionize drug discovery
Dr. David Andrews, AstraZeneca, discusses the future of small-molecule drug discovery for PPIs
Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more
Virender Singh shares his work, his average day, and favorite piece of laboratory equipment
In a ten-year project, a team from the Karl Landsteiner University of Health Sciences has identified a previously unknown role of calcium channels in the formation of synaptic connections
This week’s Reviewer in the Spotlight, Dr. Ritesh Bhole, discusses communication in science and the value of genuine product reviews, both positive and negative
Guest editor Dr. Klaus Lindpaintner discusses how innovations in glycoprotein characterization are advancing protein biology and medicine
The findings come from the largest study to date to look at inflammatory markers in COVID-19
Flow Eighteen38 will provide purified proteins and data to accelerate the success of antibody projects
The exploratory research project aims to develop novel protein expression systems via cell reprogramming
The acquisition will offer greater flow cytometry and imaging multiplexing capabilities to meet needs in protein and cell analysis research
Learn how the latest proteomics technology is driving large-scale, high-throughput studies in disease biology
From sample prep to downstream analysis, discover the products making a difference for other scientists in your field
From Alzheimer’s disease to 3D brain modeling: Watch top speakers and connect with leading neuroscience innovators online, November 17-18
From ultrafiltration and extraction to glycosylation and imaging, discover the latest technologies, top tips, and best practices for protein biology research
Watch world-renowned experts and connect with leading innovators on the hottest topics, new developments and latest technologies in neuroscience
Summa Equity Fund II acquires a majority stake in Sengenics, a functional proteomics company with a unique technology for production of full-length, correctly folded and functional proteins
